Medicus Pharma [MDPLD] vs Johnson & Johnson [JNJ] Detailed Stock Comparison

Medicus Pharma Ltd.

NASDAQ
Loading...

Johnson & Johnson

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medicus Pharma Ltd. wins in 2 metrics, Johnson & Johnson wins in 9 metrics, with 1 ties. Johnson & Johnson appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medicus Pharma Ltd. Johnson & Johnson Better
P/E Ratio (TTM) -1.47 20.49 Johnson & Johnson
Price-to-Book Ratio 3.90 6.68 Medicus Pharma Ltd.
Debt-to-Equity Ratio 0.10 60.50 Medicus Pharma Ltd.
PEG Ratio N/A 0.42 N/A
EV/EBITDA 0.00 16.84 Tie
Profit Margin (TTM) 0.00% 21.83% Johnson & Johnson
Operating Margin (TTM) 0.00% 26.72% Johnson & Johnson
EBITDA Margin (TTM) N/A 26.72% N/A
Return on Equity -841.91% 32.87% Johnson & Johnson
Return on Assets (TTM) -358.37% 13.46% Johnson & Johnson
Free Cash Flow (TTM) $-4.16M $19.31B Johnson & Johnson
Dividend Yield N/A 2.09% N/A
1-Year Return N/A 53.32% N/A
Price-to-Sales Ratio (TTM) N/A 5.66 N/A
Enterprise Value $0 $574.25B Johnson & Johnson
EV/Revenue Ratio N/A 5.96 N/A
Gross Profit Margin (TTM) N/A 67.56% N/A
Revenue per Share (TTM) $0 $40 Johnson & Johnson
Earnings per Share (Diluted) $-2.54 $11.04 Johnson & Johnson
Beta (Stock Volatility) N/A 0.33 N/A
Short % of Float N/A 1.03% N/A

Medicus Pharma Ltd. vs Johnson & Johnson Stock Performance Analysis

Loading Price Chart...

MDPLD
JNJ

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medicus Pharma Ltd.1.78%0.00%0.00%0.00%0.00%0.00%
Johnson & Johnson-2.16%1.51%3.95%-3.10%10.03%13.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medicus Pharma Ltd.N/AN/AN/AN/AN/AN/A
Johnson & Johnson53.32%46.67%48.70%108.58%263.36%290.52%

Performance & Financial Health Analysis: Medicus Pharma Ltd. vs Johnson & Johnson

MetricMDPLDJNJ
Market Information
Market Cap iN/A$555.84B
Market Cap CategoryN/AMega cap
10 Day Avg. Volume i20,0918,370,566
90 Day Avg. Volume i36,7127,752,965
Last Close$2.86$235.66
52 Week Range$1.80 - $6.00$149.04 - $251.71
% from 52W High-52.33%-6.38%
All-Time High$3.00 (Jan 24, 2025)$251.71 (Mar 02, 2026)
% from All-Time High-4.67%-6.38%
Growth Metrics
Quarterly Revenue GrowthN/A0.10%
Quarterly Earnings GrowthN/A-0.52%
Financial Health
Profit Margin (TTM) i0.00%0.22%
Operating Margin (TTM) i0.00%0.27%
Return on Equity (TTM) i-8.42%0.33%
Debt to Equity (MRQ) i0.1060.50
Cash & Liquidity
Book Value per Share (MRQ)$0.73$33.87
Cash per Share (MRQ)N/A$8.34
Operating Cash Flow (TTM) i$-4,987,008$22.21B
Levered Free Cash Flow (TTM) i$-6,784,140$43.47B
Dividends
Last 12-Month Dividend Yield iN/A2.09%
Last 12-Month Dividend iN/A$5.20

Valuation & Enterprise Metrics Analysis: Medicus Pharma Ltd. vs Johnson & Johnson

MetricMDPLD (Mar 31, 2025)JNJ (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-1.4720.49
Forward P/E iN/A17.80
PEG Ratio iN/A0.42
Price to Sales (TTM) iN/A5.66
Price to Book (MRQ) i3.906.68
Market Capitalization
Market Capitalization i$22.45M$555.84B
Enterprise Value i$0$574.25B
Enterprise Value Metrics
Enterprise to Revenue iN/A5.96
Enterprise to EBITDA i0.0016.84
Risk & Other Metrics
Beta iN/A0.33
Book Value per Share (MRQ) i$0.73$33.87

Financial Statements Comparison: Medicus Pharma Ltd. vs Johnson & Johnson

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMDPLD (2023)JNJ (2025)
Revenue/Sales i094.19B
Cost of Goods Sold iN/A30.26B
COGS % of Revenue i-32.1%
Gross Profit iN/A63.94B
Gross Margin i-67.9%
Research & Development i193,57814.67B
Operating Income (EBIT) i-3.01M25.60B
Operating Margin i-27.2%
EBITDA i-6.72M35.16B
EBITDA Margin i-37.3%
Pre-Tax Income i-6.78M32.58B
Pre-Tax Income % of Revenue i-34.6%
Income Tax iN/A5.78B
Income Tax % of Revenue i-6.1%
Net Income (Profit) i-6.78M26.80B
Profit Margin i-28.5%

Balance Sheet & Liquidity Metrics

MetricMDPLD (2023)JNJ (2025)
Cash & Equivalents i1.72M19.71B
Total Current Assets i1.89M55.62B
Total Current Assets % of Revenue i-59.1%
Total Current Liabilities i1.09M54.13B
Total Current Liabilities % of Revenue i-57.5%
Long-Term Debt iN/A39.44B
Long-Term Debt % of Revenue i-41.9%
Total Shareholders Equity i805,80081.54B
Retained Earnings i-19.18MN/A
Retained Earnings % of Revenue i-0.0%
Property, Plant & Equipment iN/A0

Cash Flow Statement Comparison

MetricMDPLD (2023)JNJ (2025)
Operating Cash Flow i-4.99M22.21B
Operating Cash Flow % of Revenue i-23.6%
Capital Expenditures iN/A-4.83B
Free Cash Flow i-4.16M19.31B
FCF Margin i-20.5%
Debt Repayment iN/A-14.09B
Common Stock Repurchase iN/A-5.95B

Short Interest & Institutional Ownership Analysis

MetricMDPLDJNJ
Shares Short iN/A22.27M
Short Ratio iN/A2.90
Short % of Float iN/A1.03%
Shares Outstanding i8.08M2.41B
Float Shares iN/A2.41B
% Held by Insiders i55.81%0.06%
% Held by Institutions i0.00%75.84%
% Held by Public i44.19%24.10%

Dividend Analysis & Yield Comparison: Medicus Pharma Ltd. vs Johnson & Johnson

MetricMDPLDJNJ
Last 12-Month Dividend iN/A$5.20
Last 12-Month Dividend Yield iN/A2.09%
3-Year Avg Annual Dividend iN/A$4.97
3-Year Avg Dividend Yield iN/A0.74%
3-Year Total Dividends iN/A$14.92
Ex-Dividend DateN/AFeb 24, 2026